news Archives - Page 56 of 100 - Journal for Clinical Studies

Current Edition

Australasia

Kerry Corning initiates phase 1 trial for narcoleptic drug

XW Laboratories Inc. has launched the first human body for the new narcoleptic drug XW10172 in Australia Phase I clinical trials to assess its safety, human tolerance...

14 March 2018 Australasia | news

Continue Reading →

Europe

UK seeks investment from health and life sciences companies worldwide

The UK is the number one destination for health and life sciences foreign direct investment in Europe. That's because the fundamentals are strong: a tax structure tha...

14 March 2018 Europe | news

Continue Reading →

Australasia

Australian scientists to develop blood test for lung cancer

The biomarker is expected to aid in predicting patients who would potentially respond to anti-PD-1 and anti-CTLA-4 immunotherapies. [caption id="" align="alignleft" w...

14 March 2018 Australasia | news

Continue Reading →

news

Cancer drug study placed on hold after patient death

US regulators have placed on hold a clinical trial testing a combination of Advaxis’ axalimogene filolisbac and AstraZeneca's Imfinzi after a patient died from respir...

13 March 2018 news | North America

Continue Reading →

news

PCI Completes Acquisition of Australia-based Pharmaceutical Packaging Professionals

Acquisition establishes an Asia Pacific Headquarters for PCI Leading pharmaceutical outsourcing services provider PCI Pharma Services (PCI) announced the completion o...

13 March 2018 news | North America

Continue Reading →

Europe

University Hospitals system adopts Magseed marker as standard of care for localisation of impalpable breast lesions

Another top 30 cancer centre looks to standardise use of Magseed to improve patient experience Endomag, the surgical guidance company, announced today that University...

13 March 2018 Europe | news

Continue Reading →

Europe

Majority of clinical trials planned in 2018 belong to oncology, says GlobalData

Cancer is one of the leading causes of morbidity and mortality across the world. Not surprisingly, oncology is going to be the top therapy area for clinical trials pl...

13 March 2018 Europe | news | North America

Continue Reading →

news

CrownBio Enters Strategic Partnership with Phanes Therapeutics to Accelerate Discovery and Development of Phanes’ Novel Oncology Agents

Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing trans...

13 March 2018 news | North America

Continue Reading →

Europe

BCI Pharma receives €3.9M ($4.7M) in public and private funding; sets up laboratory

Funds obtained from Meusinvest, private investors and the Walloon region, coupled with new facilities at the University Hospital of Liège, helped BCI to create new bi...

13 March 2018 Europe | news

Continue Reading →

news

Crown Bioscience to Showcase Scientific Expertise at Cambridge UK Symposium: Preclinical Evaluation of Novel Immunotherapies

Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing trans...

9 March 2018 news | North America

Continue Reading →